Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development

BACKGROUND: Although mRNA vaccines have been effective against multiple cancers, their efficacy against pancreatic adenocarcinoma (PAAD) remains undefined. Accumulating evidence suggests that immunotyping can indicate the comprehensive immune status in tumors and their immune microenvironment, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xing, Zhang, Gang, Tang, Tianyu, Liang, Tingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917175/
https://www.ncbi.nlm.nih.gov/pubmed/33648511
http://dx.doi.org/10.1186/s12943-021-01310-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917175/
https://www.ncbi.nlm.nih.gov/pubmed/33648511
http://dx.doi.org/10.1186/s12943-021-01310-0

Ejemplares similares